Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janice P Dutcher

Showing results (31-40 of 90) with videos related to

Pageof 9
Sort By:
Medical Oncology (Northwood, London, England)|August 22, 2009
A pilot study of carboplatin and mitoxantrone in blast crisis of chronic myeloid leukemiaJanice P Dutcher, Evelyn L Morris, Bruce Gaynor, et al.
Cancer|September 16, 2004
Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemiaMerat Karbasian-Esfahani, Peter H Wiernik, Yelena Novik, et al.
Cancer|September 21, 2004
Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinomaDavid M Nanus, Alexandria Garino, Matthew I Milowsky, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2005
The role of carbonic anhydrase IX overexpression in kidney cancerThambi Dorai, Ihor S Sawczuk, Jaromir Pastorek, et al.
British Journal of Haematology|February 12, 2004
Cardiac monitoring of patients receiving arsenic trioxide therapyDilip Unnikrishnan, Janice P Dutcher, Susan Garl, et al.
American Journal of Hematology|February 24, 2005
Strokes after intravenous gamma globulin: thrombotic phenomenon in patients with risk factors or just coincidence?Doru T Alexandrescu, Janice P Dutcher, John T Hughes, et al.
Cancer|October 14, 2005
Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group StudyJanice P Dutcher, Larry Leon, Judith Manola, et al.
Medical Oncology (Northwood, London, England)|January 13, 2004
Probable veno-occlusive disease after treatment with gemtuzumab ozogamicin in a patient with acute myeloid leukemia and a history of liver transplantation for familial hemochromatosisKevin P O'Boyle, Ashwin Murigeppa, Dharamvir Jain, et al.
Leukemia & Lymphoma|October 30, 2004
Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphomaDoru T Alexandrescu, Janice P Dutcher, Kevin O'Boyle, et al.
American Journal of Hematology|December 21, 2004
Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three casesLydia Koulova, Doru Alexandrescu, Janice P Dutcher, et al.
Pageof 9

Showing results (31-40 of 90) with videos related to

Sort By:
Pageof 9
Medical Oncology (Northwood, London, England)|August 22, 2009
A pilot study of carboplatin and mitoxantrone in blast crisis of chronic myeloid leukemiaJanice P Dutcher, Evelyn L Morris, Bruce Gaynor, et al.
Cancer|September 16, 2004
Idarubicin and standard-dose cytosine arabinoside in adults with recurrent and refractory acute lymphocytic leukemiaMerat Karbasian-Esfahani, Peter H Wiernik, Yelena Novik, et al.
Cancer|September 21, 2004
Active chemotherapy for sarcomatoid and rapidly progressing renal cell carcinomaDavid M Nanus, Alexandria Garino, Matthew I Milowsky, et al.
European Journal of Cancer (Oxford, England : 1990)|November 29, 2005
The role of carbonic anhydrase IX overexpression in kidney cancerThambi Dorai, Ihor S Sawczuk, Jaromir Pastorek, et al.
British Journal of Haematology|February 12, 2004
Cardiac monitoring of patients receiving arsenic trioxide therapyDilip Unnikrishnan, Janice P Dutcher, Susan Garl, et al.
American Journal of Hematology|February 24, 2005
Strokes after intravenous gamma globulin: thrombotic phenomenon in patients with risk factors or just coincidence?Doru T Alexandrescu, Janice P Dutcher, John T Hughes, et al.
Cancer|October 14, 2005
Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group StudyJanice P Dutcher, Larry Leon, Judith Manola, et al.
Medical Oncology (Northwood, London, England)|January 13, 2004
Probable veno-occlusive disease after treatment with gemtuzumab ozogamicin in a patient with acute myeloid leukemia and a history of liver transplantation for familial hemochromatosisKevin P O'Boyle, Ashwin Murigeppa, Dharamvir Jain, et al.
Leukemia & Lymphoma|October 30, 2004
Fatal intra-alveolar hemorrhage after rituximab in a patient with non-Hodgkin lymphomaDoru T Alexandrescu, Janice P Dutcher, Kevin O'Boyle, et al.
American Journal of Hematology|December 21, 2004
Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three casesLydia Koulova, Doru Alexandrescu, Janice P Dutcher, et al.
Pageof 9